NextPrevious

Cathy Carfagno

Assoc. Dir, IT Business Lead Global Clinical Trials Operations
Cathy Carfagno is currently the Business IT Lead for the Global Clinical Trial Operations area of Merck.  Responsible for the IT Portfolio programs that drive operational efficiencies within Merck Research Labs (MRL). In this capacity she is responsible for several multiyear programs and supports the overall execution of them and drives adoption and future strategy and alignment with Merck in general. Cathy has over 20 years at Merck and served in various roles within the business and IT. She started her career in MRL in Biostatistics and Research Data Systems (BARDS) area supporting clinical trials and led the Remote Data Entry Program. She spent seven years as a Medical Program Coordinator in the Merck J&J Joint Venture, over the counter (OTC) group and ten years in the Global Human Health division (GHH) as a manager of the Business process Improvement and Operational Excellence group supporting the Clinical development /Medical Affairs & Marketing areas. She spent seven years in MRL IT supporting Program Management for the Clinical Trial Operations area and the Account Manager of the CPAC Portal. Three years in Enterprise Integration and Customer Collaboration (EICC). In this capacity, she was Account Lead responsible for the overall change execution and communication planning for the EngageZone (EZM) External Partner Program an enterprise wide multiyear cross divisional program and its development efforts. Cathy’s interests lay primarily in driving change and transformation Initiatives across Merck and the Industry. She chaired the Clinical Portal Forum 2010-2012 and Industry workshops to outline the biggest problems the industry faces in conducting Clinical trials. She is very interested in innovation and new technologies supporting Merck’s IT Strategy. Most recently she is a Merck consultant for the TransCelerate Bio Pharm initiative. Cathy holds a BA in Business Administration, MS in Education and a certified PMP, Scrum Master (CSM), Sigma Green Belt and Change Agent Capabilities (CAC).

Merck & Co

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company has a collaboration agreement with Adaptimmune Therapeutics plc; and a research agreement with Proteros Biostructures to develop small molecule compounds for the treatment of various cancers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.